Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Walter Berger

Spatio-Temporally Precise Activation of Engineered Receptor Tyrosine Kinases by Light

EMBO Journal

English

Inside Back Cover: An Organoruthenium Anticancer Agent Shows Unexpected Target Selectivity for Plectin (Angew. Chem. Int. Ed. 28/2017)

Angewandte Chemie - International Edition

Catalysis

Chemistry

2017

English

Impact of CYP24A1 Overexpression on Growth of Colorectal Tumour Xenografts in Mice Fed With Vitamin D and Soy

International Journal of Cancer

Cancer Research

Oncology

2015

English

{(1r,2r,4r)-4-Methyl-1,2-Cyclohexanediamine}oxalatoplatinum(II): A Novel Enantiomerically Pure Oxaliplatin Derivative Showing Improved Anticancer Activity in Vivo

Journal of Medicinal Chemistry

Drug Discovery

Molecular Medicine

2010

English

The First Anticancer Tris(pyrazolyl)borate Molybdenum(IV) Complexes: Tested in Vitro and in Vivo – A Comparison of O,O‐, S,O‐, and N,N‐chelate Effects

Chemistry - A European Journal

English

Results of the Extended Analysis for Cancer Treatment (EXACT) Trial: A Prospective Translational Study Evaluating Individualized Treatment Regimens in Oncology

Oncotarget

Oncology

2019

English

EGFR-targeting Peptide-Coupled Platinum(IV) Complexes

Journal of Biological Inorganic Chemistry

Biochemistry

Inorganic Chemistry

2017

English

Poly(lactic Acid) Nanoparticles of the Lead Anticancer Ruthenium Compound KP1019 and Its Surfactant-Mediated Activation

Dalton Transactions

Inorganic Chemistry

2014

English

Comparative Studies of Oxaliplatin-Based Platinum(iv) Complexes in Different in Vitro and in Vivo Tumor Models

English

Ecdysteroids Sensitize MDR and Non-MDR Cancer Cell Lines to Doxorubicin, Paclitaxel, and Vincristine but Tend to Protect Them From Cisplatin

BioMed Research International

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Walter Berger

Spatio-Temporally Precise Activation of Engineered Receptor Tyrosine Kinases by Light

Inside Back Cover: An Organoruthenium Anticancer Agent Shows Unexpected Target Selectivity for Plectin (Angew. Chem. Int. Ed. 28/2017)

Impact of CYP24A1 Overexpression on Growth of Colorectal Tumour Xenografts in Mice Fed With Vitamin D and Soy

{(1r,2r,4r)-4-Methyl-1,2-Cyclohexanediamine}oxalatoplatinum(II): A Novel Enantiomerically Pure Oxaliplatin Derivative Showing Improved Anticancer Activity in Vivo

The First Anticancer Tris(pyrazolyl)borate Molybdenum(IV) Complexes: Tested in Vitro and in Vivo – A Comparison of O,O‐, S,O‐, and N,N‐chelate Effects

Results of the Extended Analysis for Cancer Treatment (EXACT) Trial: A Prospective Translational Study Evaluating Individualized Treatment Regimens in Oncology

EGFR-targeting Peptide-Coupled Platinum(IV) Complexes

Poly(lactic Acid) Nanoparticles of the Lead Anticancer Ruthenium Compound KP1019 and Its Surfactant-Mediated Activation

Comparative Studies of Oxaliplatin-Based Platinum(iv) Complexes in Different in Vitro and in Vivo Tumor Models

Ecdysteroids Sensitize MDR and Non-MDR Cancer Cell Lines to Doxorubicin, Paclitaxel, and Vincristine but Tend to Protect Them From Cisplatin